Development of a self-treatment approach for patients with COPD and comorbidities: An ongoing learning process

Journal of Thoracic Disease

Volumn 6, Issue 11, 2014, Pages 1597-1605

  Effing, Tanja W ^a,b   Lenferink, Anke ^c   Buckman, Julie ^b   Spicer, Deborah ^a   Cafarella, Paul A ^a,b   Burt, Morton G ^b,d   Bassett, Katherine L ^a   van Ommeren, Clara ^c   Anesbury, Sally ^b   van der Valk, Paul D L P M ^c   Frith, Peter A ^a,b   van der Palen, Job ^c,e  

^a Central Adelaide Local Health Network   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d REPATRIATION GENERAL HOSPITAL   (Australia)

^e UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Chronic obstructive; Comorbidity; Pulmonary disease; Self care

Indexed keywords

GLUCOSE;

ANXIETY DISORDER; BEHAVIOR CHANGE; CASE MANAGEMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE EXACERBATION; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL EDUCATION; PATIENT SAFETY; REVIEW; SELF CARE; SYMPTOM;

EID: 84917686114     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.11.14     Document Type: Review

References (34)

1. Australia's health 2010: The twelfth biennial health report of the Australian Institute of Health and Welfare. Canberra: The Australian Institute of Health and Welfare 2010.
2. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-9.
3. Economic Impact of COPD and Cost-Effective Solutions. Available online: http://www.rnig.org.au/docs/EconomicImpactofCOPDandCostEffectiveSolutions-226.pdf
4. Frith PA, Cafarella PA, Duffy JM. Chronic obstructive pulmonary disease (COPD) is a major personal and public health burden in Australia. Aust N Z J Public Health 2008;32:139-41.
5. Foster TS, Miller JD, Marton JP, et al. Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature. COPD 2006;3:211-8.
6. Wilson DH, Tucker G, Frith P, et al. Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. Med J Aust 2007;186:408-11.
7. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007;29:1224-38.
8. Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014;3:CD002990.
9. Effing TW, Bourbeau J, Vercoulen J, et al. Self-management programmes for COPD: moving forward. Chron Respir Dis 2012;9:27-35.
10. Walters JA, Turnock AC, Walters EH, et al. Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010;CD005074.
11. Effing T, Kerstjens H, van der Valk P, et al. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009;64:956-62.
12. Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010;182:890-6.
13. Trappenburg JC, Monninkhof EM, Bourbeau J, et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax 2011;66:977-84.
14. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-85.
15. Anecchino C, Rossi E, Fanizza C, et al. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis 2007;2:567-74.
16. Holguin F, Folch E, Redd SC, et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005;128:2005-11.
17. Crockett AJ, Cranston JM, Moss JR, et al. An association between length of stay and co-morbidity in chronic airflow limitation. Int J Qual Health Care 2000;12:41-6.
18. Australian Centre for Asthma Monitoring 2006. Asthma and chronic obstructive pulmonary disease among older people in Australia: deaths and hospitalisations. AIHW cat. no. ACM 7. Canberra: AIHW.
19. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2014. Available online: http://www.goldcopd.com/uploads/users/files/GOLD_Report_2014_Oct30.pdf
20. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.
21. Fan VS, Gaziano JM, Lew R, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med 2012;156:673-83.
22. Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010;182:890-6.
23. Bourbeau J, Saad N. Integrated care model with self-management in chronic obstructive pulmonary disease: from family physicians to specialists. Chron Respir Dis 2013;10:99-105.
24. Monninkhof E, van der Valk P, van der Palen J, et al. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J 2003;22:815-20.
25. Effing T, Zielhuis G, Kerstjens H, et al. Community based physiotherapeutic exercise in COPD self-management: a randomised controlled trial. Respir Med 2011;105:418-26.
26. Lenferink A, Frith P, van der Valk P, et al. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol. Contemp Clin Trials 2013;36:81-9.
27. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
28. Fowler C, Kirschner M, Van Kuiken D, et al. Promoting self-care through symptom management: a theory-based approach for nurse practitioners. J Am Acad Nurse Pract 2007;19:221-7.
29. National Heart Foundation of Australia. New Heart attack action plan. In: National Heart Foundation of Australia, editor 2009.
30. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
31. Burt MG, Roberts GW, Aguilar-Loza NR, et al. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metab 2011;96:1789-96.
32. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006;61:284-9.
33. Burt MG, Roberts GW, Aguilar-Loza NR, et al. Relationship between glycaemia and length of hospital stay during an acute exacerbation of chronic obstructive pulmonary disease. Intern Med J 2013;43:721-4.
34. Davis TC, Wolf MS, Bass PF 3rd, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med 2006;145:887-94.